Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: A dose-finding study

C. Ficorella; M. F. Morelli; E. Ricevuto; K. Cannita; G. Porzio; P. Lanfiuti Baldi; G. Cianci; Z. C. Di Rocco; C. Natoli; N. Tinari; F. De Galitiis; F. Calista; P. Marchetti

Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: A dose-finding study

C. Ficorella, M. F. Morelli, E. Ricevuto, K. Cannita, G. Porzio, P. Lanfiuti Baldi, G. Cianci, Z. C. Di Rocco, C. Natoli, N. Tinari, F. De Galitiis, F. Calista, P. Marchetti

Istituto Dermopatico dell'Immacolata , IDI

Research output: Contribution to journal › Article › peer-review

Abstract

A dose-finding study was undertaken to determine the maximum-tolerated dose, and the recommended dose of docetaxel in combination with 12-h timed (22:00-10:00) flat infusion of 5-fluorouracil (5-FU) in metastatic breast cancer patients. This schedule seems to reduce the occurrence of stomatitis of the docetaxel and infusional 5-FU regimen.

Original language	English
Pages (from-to)	618-620
Number of pages	3
Journal	British Journal of Cancer
Volume	91
Issue number	4
Publication status	Published - Aug 16 2004

Keywords

5-fluorouracil
Breast cancer
Docetaxel

ASJC Scopus subject areas

Cancer Research
Oncology

Cite this

Ficorella, C., Morelli, M. F., Ricevuto, E., Cannita, K., Porzio, G., Lanfiuti Baldi, P., Cianci, G., Di Rocco, Z. C., Natoli, C., Tinari, N., De Galitiis, F., Calista, F., & Marchetti, P. (2004). Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: A dose-finding study. British Journal of Cancer, 91(4), 618-620.

Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer : A dose-finding study. / Ficorella, C.; Morelli, M. F.; Ricevuto, E.; Cannita, K.; Porzio, G.; Lanfiuti Baldi, P.; Cianci, G.; Di Rocco, Z. C.; Natoli, C.; Tinari, N.; De Galitiis, F.; Calista, F.; Marchetti, P.

In: British Journal of Cancer, Vol. 91, No. 4, 16.08.2004, p. 618-620.

Research output: Contribution to journal › Article › peer-review

Ficorella, C, Morelli, MF, Ricevuto, E, Cannita, K, Porzio, G, Lanfiuti Baldi, P, Cianci, G, Di Rocco, ZC, Natoli, C, Tinari, N, De Galitiis, F, Calista, F & Marchetti, P 2004, 'Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: A dose-finding study', British Journal of Cancer, vol. 91, no. 4, pp. 618-620.

Ficorella, C. ; Morelli, M. F. ; Ricevuto, E. ; Cannita, K. ; Porzio, G. ; Lanfiuti Baldi, P. ; Cianci, G. ; Di Rocco, Z. C. ; Natoli, C. ; Tinari, N. ; De Galitiis, F. ; Calista, F. ; Marchetti, P. / Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer : A dose-finding study. In: British Journal of Cancer. 2004 ; Vol. 91, No. 4. pp. 618-620.

@article{2b0b2697bec548b5a501ff214d3de420,

title = "Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: A dose-finding study",

abstract = "A dose-finding study was undertaken to determine the maximum-tolerated dose, and the recommended dose of docetaxel in combination with 12-h timed (22:00-10:00) flat infusion of 5-fluorouracil (5-FU) in metastatic breast cancer patients. This schedule seems to reduce the occurrence of stomatitis of the docetaxel and infusional 5-FU regimen.",

keywords = "5-fluorouracil, Breast cancer, Docetaxel",

author = "C. Ficorella and Morelli, {M. F.} and E. Ricevuto and K. Cannita and G. Porzio and {Lanfiuti Baldi}, P. and G. Cianci and {Di Rocco}, {Z. C.} and C. Natoli and N. Tinari and {De Galitiis}, F. and F. Calista and P. Marchetti",

year = "2004",

month = aug,

day = "16",

language = "English",

volume = "91",

pages = "618--620",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer

T2 - A dose-finding study

AU - Ficorella, C.

AU - Morelli, M. F.

AU - Ricevuto, E.

AU - Cannita, K.

AU - Porzio, G.

AU - Lanfiuti Baldi, P.

AU - Cianci, G.

AU - Di Rocco, Z. C.

AU - Natoli, C.

AU - Tinari, N.

AU - De Galitiis, F.

AU - Calista, F.

AU - Marchetti, P.

PY - 2004/8/16

Y1 - 2004/8/16

N2 - A dose-finding study was undertaken to determine the maximum-tolerated dose, and the recommended dose of docetaxel in combination with 12-h timed (22:00-10:00) flat infusion of 5-fluorouracil (5-FU) in metastatic breast cancer patients. This schedule seems to reduce the occurrence of stomatitis of the docetaxel and infusional 5-FU regimen.

AB - A dose-finding study was undertaken to determine the maximum-tolerated dose, and the recommended dose of docetaxel in combination with 12-h timed (22:00-10:00) flat infusion of 5-fluorouracil (5-FU) in metastatic breast cancer patients. This schedule seems to reduce the occurrence of stomatitis of the docetaxel and infusional 5-FU regimen.

KW - 5-fluorouracil

KW - Breast cancer

KW - Docetaxel

UR - http://www.scopus.com/inward/record.url?scp=4344672492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344672492&partnerID=8YFLogxK

M3 - Article

C2 - 15292944

AN - SCOPUS:4344672492

VL - 91

SP - 618

EP - 620

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 4

ER -

Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: A dose-finding study

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this